Author

Stephen Joseph Bagley

University of PennsylvaniaORCID 0000-0002-7117-0539Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Abhishek Venketeswaran· 1 shared Alex M. LiiD· 1 shared Anette U. DuensingiD· 1 shared Angelo AngioneiD· 1 shared Anthony Richard CilloiD· 1 shared Antonio Corral Tarbay· 1 shared Aparna Rao· 1 shared Arati Suvas DesaiiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek Venketeswaran

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell stem cellPeer-reviewedDec 9, 2024

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy

Meghan T. Logun, Xin Wang, Yusha Y. Sun…·Donald M. O’Rourke

The paper shows that patient-derived glioblastoma organoids can reflect CAR-T cell treatment responses in real-time, correlating with clinical outcomes in patients.

126 citationstop 1%

humanorganoid / primary culture

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 9, 2024

All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis

Aparna Rao, Xiaoran Zhang, Anthony Richard Cillo…·Nduka Amankulor

This study shows that all-trans retinoic acid (ATRA) improves immune response in IDH-mutant gliomas by restoring the RA pathway, leading to tumor regression in mouse models and a clinical trial for human patients.

2 citations

mousehuman

𝕏 PostBluesky